BioSpace News Archive

Pharm Country

Octapharma USA Grant Supports Mission of First Hemophiliac to Climb the Seven Summits of the World

Octapharma USA has provided a grant to support the final leg of the inspirational journey of Chris Bombardier, who hopes to become the first person with severe Hemophilia to climb the Seven Summits of the world.

October 31, 2017

·

3 min read

BioMidwest

Sermonix Pharmaceuticals Announces Recent Closure of $4.2 Million Seed Preferred Equity Bridge to Fund Operations, Prepare for Phase II Breast Cancer Study

Sermonix announced its recent completion of a $4.2 million Seed Preferred Equity Bridge financing round to fund ongoing operations and prepare for entry of investigational drug lasofoxifene into a Phase II clinical trial.

October 31, 2017

·

4 min read

Business

Oncobiologics Announces Closing of Strategic Partnership Deal With GMS Tenshi Holdings

The deal builds a strategic partnership to accelerate the commercialization of Oncobiologics’ biosimilar candidates.

October 31, 2017

·

5 min read

Biotech Bay

CareDx Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Eight new employees were awarded grants of options to purchase CareDx common stock under NASDAQ Listing Rule 5635(c)(4).

October 31, 2017

·

1 min read

Business

Novelion Therapeutics Expands Leadership Team With Appointment of Jeffrey Hackman as Chief Operating Officer

Jeffrey Hackman was most recently senior vice president, head of the US Internal Medicine and Oncology franchises for Shire.

October 31, 2017

·

6 min read

data also show fingolimod-treated patients had sig

Policy

Novartis Submits Application to FDA for Kymriah (Tisagenlecleucel) in Adult Patients With R/R DLBCL, Seeking Second Indication for First-Ever FDA Approved CAR-T Therapy

If approved, this would be the second indication for Kymriah.

October 31, 2017

·

13 min read

Drug Development

DelMar Pharma Presents Data Supporting VAL-083 as a Component of Combination Chemotherapy Regimens for the Treatment of Solid Tumors including Brain and Ovarian Cancer

DelMar presented a poster entitled “DNA Damaging Agent Dianhydrogalactitol (VAL-083) Targets Homologous Repair (HR) Pathway and Suggests Combination Therapy with topoisomerase inhibitors and PARP inhibitors.”

October 31, 2017

·

6 min read

BioForest

BioLife Solutions and SAVSU Providing Enhanced Cold Chain Technologies for 8 UCSF Clinical Trials of Treg Cell Therapies

BioLife Solutions today announced both companies are providing their respective enhanced cold chain technologies for use in 8 active and pending clinical trials conducted by the Diabetes Center and Department of Surgery at the UCSF.

October 31, 2017

·

6 min read

Business

Syndax to Announce Third Quarter 2017 Financial Results and Host Conference Call and Webcast on November 7, 2017

Syndax announced today that it will release its third quarter 2017 financial results on Tuesday, November 7, 2017, after the close of the U.S. financial markets.

October 31, 2017

·

4 min read

Business

IDEXX Labs Announces Third Quarter Results

IDEXX Labs reports revenues for the third quarter of 2017 of $492M, an increase of 10% compared to the prior year period on a reported basis and 9% on an organic basis.

October 31, 2017

·

65 min read